Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick al nicotinic receptor

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 285-295

  Maggi, L ^a   Palma, E ^a   Eusebi, F ^a   Moretti, M ^a   Balcstra, B ^a   Clementi, F ^a   Gotti, C ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Chick; Epibatidine; Methyllycaconitine; MG624; Muscle nicotinic receptors; Neuronal nicotinic receptors; Ocbungarotoxin; Oocytes; Subtypes

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; EPIBATIDINE; METHYLLYCACONITINE; MUTANT PROTEIN; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; STILBENE DERIVATIVE; STILONIUM IODIDE; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN; CHICKEN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; ELECTROPHYSIOLOGY; GENETIC TRANSFECTION; MEMBRANE CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL;

ACETYLCHOLINE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES; BINDING, COMPETITIVE; BUNGAROTOXINS; CHICKENS; CHOLINERGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOCHEMISTRY; MEMBRANE POTENTIALS; MUSCLES; MUTATION; NEURONS; OOCYTES; QUATERNARY AMMONIUM COMPOUNDS; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; STILBENES; XENOPUS;

EID: 0032894534     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702299     Document Type: Article

References (50)

1. ALBUQUERQUE E.X., ALKONDON, M., PEREIRA, E., CASTRO, N.G., REINHARDT, S., SCHRATTENHOLZ, A., BARBOSA, C., BONFANTE-CABARCAS, R., ARACAYA, Y., EISENBERG, H. & MAELICKE, A. (1997). Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther., 280, 1117-1136.
2. ANAND, R., PENG, X. & LINDSTROM, J. (1993). Homomeric and native a7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett., 327,241-246.
3. BERTRAND, D., COOPER, E., VALERA, S., RUNGGER, D. & BALLIVET, M. (1991). Electrophysiology of neuronal nicotinic acetylcholine receptors expressed in Xenopus oocyte, following nuclear injection of genes and cDNAs, Afeth. Neurosci., 4, 174193.
4. BERTRAND, D., DEVILLERS-THIÉRY, A., REVAH, F., GALZI, J.-L., HUSSY, N., MULLE, C., BERTRAND, S., BALLIVET, M. & CHANCEUX, J.-P. (1992). Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc. Natl. Acad. Sei. U.S.A., 89, 1261 -1265.
5. BERTRAND, D., GALZI, J.-L., DEVILLERS-THIÉRY, A., BERTRAND, S. & CHANCEUX, J.-P. (1993). Stratification of the channel domain in neurotransmitter receptors. Curr. Op. Cell Biol., 5, 688-693.
6. BERTRAND, S., DEVILLERS-THIÉRY, A., PALMA, E., BUISSON, B., ELDESTEIN S., CORRINGER, P.-J., CHANGEUX, J.-P., & BERTRAND, D. (1997). Paradoxical allosteric effects of competitive inhibitors on neuronal a7 nicotinic receptors. Neuroreport, 8, 3591-3596.
7. COLQUHOUN D. & RANG, S. (1976). Effects of inhibitors on the binding of iodinated a-Bungarotoxin to acetylcholine receptors in rat muscle. Mol. Pharmacol., 12, 519-535.
8. CONROY, W.G., VERNALLIS, A.B. & BERG, O.K. (1992). The a5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron, 9, 679691.
9. CONROY, W.G. & BERG, O.K. (1995). Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem., 270, 4424-4431.
10. CORRIVEAU, R.A., ROMAND, S.J., CONROY, W.G., OLIVA, W.G. & BERG, O.K. (1995). Expression of neuronal acetylcholine receptor genes in vertebrate skeletal muscle during development. J. Neurosci.. 15, 1372-1382.
11. COUTURIER, S., BERTRAND, D., MATTER, J.-M., HERNANDEZ, M.C., BERTRAND, S., MILLAR, N., VALERA, S. & BARRAS, T. (1990). A neuronal nicotinic acetylcholine receptor subunit (a7) is developmentally regulated and forms a homo-oligomeric channel blocked by a-Bgtx. Neuron, 5, 847-856.
12. COVERNTON, P., KOJIMA, H., SIVILOTTI, L., G1BB, A. & COLQUHOUN, D. (1994). Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pair expressed in Xenopus oocytes; Colquhoun D J. Physiol.. 481, 27-34.
13. DANI, J.A. & HEINEMANN, S. (1996). Molecular and cellular aspects of nicotine abuse. Neuron., 16, 905-908.
14. DECKER, M.W., BRIONI, J.D., BANNON, A.W. & ARNERIC, S.P. (1995). Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sei.. 56, 545-570.
15. FORSAYETH JR. & KOBRIN, E. (1997). Formation of oligomers containing the /J3 and /34 subunits of the rat nicotinic receptor. J. Neurosci.,1531-1538.
16. FUCILE, S., BARABINO, B., PALMA, E., GRASSI, F., LIMATOLA, C., MILEO, A., ALEMa, S., BALLIVET, M. & EUSEBI, F. (1997). a5 subunit forms functional a3/Ma5 nicotinic AChRs in transfected human cells. Neuroreport, 8, 2433-2436.
17. FUCILE, S., MATTER, J.-M., ERKMAN, L., RAGOZZINO, D., BARABINO, B., GRASSI, F., ALEMa S., BALLIVET, M. & EUSEBI, F. (1998). The neuronal a6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells. E. J. Neurosci., 10, 172-178.
18. GALZl.-Jr-C., BERTRAND, S., CORRINGER, P.-J., CHANCEUX, J.-P. & BERTRAND, D. (1996). Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J., 15, 5824-5832.
19. GERZANICH, V., PENG, X., WANG, F., WELLS, G., ANAND, R., FLETCHER, S. & LINDSTROM, J. (1995). Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol., 48, 774-782.
20. GOTTI, C, BALESTRA, B., MANTEGAZZA, R., TZARTOS, S., MORETTI, M. & CLEMENTI, F. (1997b). Detection of antibody classes and subpopulations in MG patients using a new non radioactive enzyme immunoassay. Muscle & Ncr, 20,800-808.
21. GOTTI, C., BALESTRA, B., MORETTI, M., ROVATI, G.E., MAGGI, L., ROSSONI, G-, BERTI, F., VILLA, L., PALLAVICINI, M. & CLEMENTI, F. (I998). 4-Oxystilbene compounds are selective ligands for neuronal nicotinic otBungarotoxin receptors. Br. J. Pharmacol.. 124, 1197-1206.
22. GOTTI, C., FORNASARI, D. & CLEMENTI, F. (1997a). Human neuronal nicotinic receptors. Progr. Neurobiol., 53, 199-237.
23. GOTTI, C, HANKE, W., MORETTI, M., BALLIVET, M., CLEMENTI, F. & BERTRAND, D. (1994). Pharmacology and biophysical properties of al and oc7-a8 ot-Bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Enr. J. Neurosci., 6, 12811291.
24. GOTTI, C, MORETTI, M., MAGGI, R., LONGHI, R., HANKE, W., KLINKE, N. & CLEMENTI, F. (1997c). 7 and 08 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci., 9, 1201 -1211.
25. JOHNSON, D., MARTINEZ, J., ELGOYHEN, A., HEINEMANN, S. & MCINTOSH, J.M. (1995). a-Conotoxin Iml exhibits subtypespecific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric a7 and 9 receptors. Mol. Pharmacol., 48, 194-199.
26. KEM, W., MAHNIR, V., PAPKE, R. & LINGLE, C. (1997). Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxinsensitive nicotinic receptors. J. Pharmacol. Exp. Ther., 283,979992.
27. KURYATOV, A., GERZANICH, V., NELSON, M., OLALE, F. & LINDSTROM, J. (1997). Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human 0.2 nicotinic acetylcholine receptor. J. Neurosci., 17, 9035-9047.
28. LENA, C. & CHANGEUX, J.-P. (1997). Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders. Curr. Op. Neurobiol., 7, 674-682.
29. LEWIS, T., HARKNESS, P., SILVIOTTI, L., COLQUHOUN, D. & MILLAR, N. (1997). The ion channel of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type. J. Physiol., 505, 299-306.
30. LINDSTROM, J. (1997). Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol., 15, 193-222.
31. MANTEGAZZA, P. & TOMMASINI, R. (1955). Central antinicotinic activity of 4-oxystiIbene and 4-oxydiphenyIethane derivatives. Arch. Int. Pharmacodyn., 4, 371-403.
32. MCGEHEE, D.S. & ROLE, LAV. (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Anna. Rev. Physiol., 57, 521 -546.
33. MILEDI, R., PARKER, I. & SUMIKAWA, K. (1989). Fidia Research Foundation Neuroscience Award Lectures, 1987-1988 (Raven, New York), 3, 57-90.
34. MILEO, A.M., PALMA, E., POLENZANI, L., LIMATOLA, C, GRASSI, F. & EUSEBI, F. (1995). Protein kinase C modulates exogenous acetylcholine current in Xenopus oocytes. J. Neurosci. Res., 41, 443-451.
35. MUNSON, P.J. & RODBOARD, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem.. 107, 220-239.
36. PALMA, E., BERTRAND, S., BINZONI, T. & BERTRAND, D. (1996a). Neuronal nicotinic al receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J. Physiol., 491.1, 151-161.
37. PALMA, E., MILEO, A.M., EUSEBI, F. & MILEDI, R. (1996b). Threonine-for-Ieucine mutation within domain M2 of the neuronal a? nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Proc. Nail. Acad. Sei. U.S.A., 93, 11231-11235.
38. REVAH, F., BERTRAND, D., GALZI, J.-L., DEVILLERS-THIÉRY, A., MULLE, C, HUSSY, N., BERTRAND, S., BALLIVET, M. & CHANCEUX, J.-P. (1991). Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature. 353, 846-849.
39. ROLE, L.W. & BERG, K.D. (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron., 16, 1077-1085.
40. ROVATI, G.E., RABIN, D. & MUNSON, P.J. (1991). Analysis, design and optimization of ligand binding experiments. In Horizon in Endocrinology (Vol II). Eds. Maggi, M. & Geenen, E.V. pp. 155167. New York: Serono Symposia Publication from Raven Press.
41. SARGENT, P.B. (1993). The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci., 16, 403-443.
42. TZARTOS, S., LANGEBERG, L., HOCHSCHWENDER, S., SWANSON, L. & LINDSTROM, J. (1986). Characterization of monoclonal antibodies to denaturated Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity. J. NeuroiiiimunoL, 10, 235-253.
43. ULLIAN, E. & SARGENT, P. (1995). Pronounced cellular diversity and extrasynaptic localization of nicotinic acetylcholine receptor subunit immunoreactivities in the chicken pretectum. J. Neurosci., 15, 7012-7023.
44. VERNALLIS, A.B., CONROY, W.G. & BERG, O.K. (1993). Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron, 10, 451 -464.
45. WARD, J.M., COCKCROFT, V.B., LUNT, G.G., SMILE, F.S. & WONNACOTT, S. (I990). Methyllycaconitine: a selective probe for neuronal abungarotoxin binding sites; FEES Lett., 270, 4548.
46. WHITING, P.J. & LINDSTROM, J.M. (1988). Characterization of bovine and human neuronal nicotinic receptors using monoclonal antibodies. J. Neurosci., 8, 3395-3404.
47. WHITING, P.J., LIU, R., MORLEY, B.J. & LINDSTROM, J.M. (1987). Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies. J. Neurosci., 7, 4005-4016.
48. WHITING, P., SCHOEPFER, R., LINDSTROM, J. & PRIESTLEY, T. (1991a). Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. fol. Pharmacol., 40, 463-472.
49. WHITING, P.]., SCHOEPFER, R., CONROY, W.G., GORE, M.J., KEYSER, K.T., SHIMASAKI, S., ESCH, F. & LINDSTROM, J.M. (1991b). Expression of nicotinic acetylcholine receptor subtypes in brain and retina. Brain Res., 10, 61-70.
50. WONNACOTT, S. (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci., 20, 92-98.